Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 05, 2015 7:23 AM ET

Healthcare Providers and Services

Company Overview of Spotlight Innovation, Inc.

Company Overview

Spotlight Innovation, Inc. provides solutions for healthcare-focused companies commercializing healthcare intellectual property developed by centers of academia in the United States. The company focuses on identifying, validating, and acquiring/cooperating with early stage companies developing healthcare technologies, including pharmaceuticals, devices and equipment, diagnostic products, and healthcare IT. It also develops Immunoplex, a vaccine for infectious diseases and oncology immunotherapy. In addition, the company, through its subsidiary, Celtic Biotech Iowa, Inc., develops therapeutic products for the treatment of solid cancers and pain in humans. Spotlight Innovation, Inc. was founde...

6750 Westown Parkway

Suite 200-226

West Des Moines, IA 50266

United States

Founded in 2012

1 Employees

Phone:

515-274-9087

Key Executives for Spotlight Innovation, Inc.

Chairman, Chief Executive Officer and President
Age: 42
Total Annual Compensation: $120.0K
Chief Financial Officer
Age: 75
Total Annual Compensation: $23.5K
Compensation as of Fiscal Year 2014.

Spotlight Innovation, Inc. Key Developments

Spotlight Innovation, Inc. announced delayed 10-Q filing

On 05/15/2015, Spotlight Innovation, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Spotlight Innovation Seeks Acquisitions

Spotlight Innovation, Inc. (OTCPK:STLT) closed on $2.5 million financing. "The capital from this financing allows us to continue focusing on identifying and growing our targeted healthcare intellectual property acquisition opportunities," said Cris Grunewald, President and Chief Executive Officer of Spotlight Innovation.

Spotlight Innovation, Inc. announced delayed annual 10-K filing

On 03/31/2015, Spotlight Innovation, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Similar Private Companies By Industry

Company Name Region
Happy Harry's Health Care, Inc. United States
Palisades General Care, Inc. United States
Nutrex Hawaii Inc. United States
Kemper Medical, Inc. United States
Paquin Healthcare Companies, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
March 31, 2015
--
Merger/Acquisition
October 14, 2014
Memcine Pharmaceuticals Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Spotlight Innovation, Inc., please visit www.spotlightinnovation.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.